Tags

Type your tag names separated by a space and hit enter

Incidence of Iron Deficiency and Iron Deficient Anemia in Elite Runners and Triathletes.
Clin J Sport Med 2017; 27(5):493-498CJ

Abstract

OBJECTIVE

To assess the incidence of iron deficiency (ID), and iron deficient anemia (IDA) within a cohort of highly trained runners and triathletes, and to examine the association of oral iron supplementation history with serum ferritin (sFe) and hemoglobin (Hb) concentrations.

METHODS

A retrospective analysis of routine blood test data taken from 2009 to 2015 from (n = 38) elite level runners and triathletes between the ages of 21 to 36 years. Oral iron supplement intake was assessed through a questionnaire.

RESULTS

Triathletes (female, FT; male, MT) and runners (female, FR; male, MR) had higher incidence of at least 1 episode of ID (FT 60.0%, MT 37.5%, FR 55.6%, MR 31.3%) compared with values reported in the literature for endurance athletes (20%-50% females, 0%-17% males). Male triathletes and runners had a higher incidence of IDA than their female teammates (25% MT, 20% FT, 6.3% for MR, 0% FR), a finding which has previously not been reported. Hemoglobin concentrations were low, with incidence of Hb <140 g/L in men occurring at least once in 87.5% of triathletes, and 31.3% of runners, and Hb <120 g/L in women occurring at least once in 20% of triathletes, but 0% of runners. Although the athletes were appropriately treated with oral iron (mean 94 ± 115 mg/d), there was no observed correlation between iron intake and sFe or Hb.

CONCLUSIONS

Even with monitoring and treatment in place, ID and IDA are significant concerns for the health and performance of elite runners and triathletes, and this issue affects males and females.

Authors+Show Affiliations

*Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, ON, Canada; †Health and Performance Centre, University of Guelph, Guelph, ON, Canada; ‡Department of Family Medicine, McMaster University, Hamilton, ON, Canada; and §The International Olympic Committee's Medical Commission.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

27606953

Citation

Coates, Alexandra, et al. "Incidence of Iron Deficiency and Iron Deficient Anemia in Elite Runners and Triathletes." Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine, vol. 27, no. 5, 2017, pp. 493-498.
Coates A, Mountjoy M, Burr J. Incidence of Iron Deficiency and Iron Deficient Anemia in Elite Runners and Triathletes. Clin J Sport Med. 2017;27(5):493-498.
Coates, A., Mountjoy, M., & Burr, J. (2017). Incidence of Iron Deficiency and Iron Deficient Anemia in Elite Runners and Triathletes. Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine, 27(5), pp. 493-498. doi:10.1097/JSM.0000000000000390.
Coates A, Mountjoy M, Burr J. Incidence of Iron Deficiency and Iron Deficient Anemia in Elite Runners and Triathletes. Clin J Sport Med. 2017;27(5):493-498. PubMed PMID: 27606953.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Incidence of Iron Deficiency and Iron Deficient Anemia in Elite Runners and Triathletes. AU - Coates,Alexandra, AU - Mountjoy,Margo, AU - Burr,Jamie, PY - 2016/9/9/pubmed PY - 2017/10/31/medline PY - 2016/9/9/entrez SP - 493 EP - 498 JF - Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine JO - Clin J Sport Med VL - 27 IS - 5 N2 - OBJECTIVE: To assess the incidence of iron deficiency (ID), and iron deficient anemia (IDA) within a cohort of highly trained runners and triathletes, and to examine the association of oral iron supplementation history with serum ferritin (sFe) and hemoglobin (Hb) concentrations. METHODS: A retrospective analysis of routine blood test data taken from 2009 to 2015 from (n = 38) elite level runners and triathletes between the ages of 21 to 36 years. Oral iron supplement intake was assessed through a questionnaire. RESULTS: Triathletes (female, FT; male, MT) and runners (female, FR; male, MR) had higher incidence of at least 1 episode of ID (FT 60.0%, MT 37.5%, FR 55.6%, MR 31.3%) compared with values reported in the literature for endurance athletes (20%-50% females, 0%-17% males). Male triathletes and runners had a higher incidence of IDA than their female teammates (25% MT, 20% FT, 6.3% for MR, 0% FR), a finding which has previously not been reported. Hemoglobin concentrations were low, with incidence of Hb <140 g/L in men occurring at least once in 87.5% of triathletes, and 31.3% of runners, and Hb <120 g/L in women occurring at least once in 20% of triathletes, but 0% of runners. Although the athletes were appropriately treated with oral iron (mean 94 ± 115 mg/d), there was no observed correlation between iron intake and sFe or Hb. CONCLUSIONS: Even with monitoring and treatment in place, ID and IDA are significant concerns for the health and performance of elite runners and triathletes, and this issue affects males and females. SN - 1536-3724 UR - https://www.unboundmedicine.com/medline/citation/27606953/Incidence_of_Iron_Deficiency_and_Iron_Deficient_Anemia_in_Elite_Runners_and_Triathletes L2 - http://Insights.ovid.com/pubmed?pmid=27606953 DB - PRIME DP - Unbound Medicine ER -